# NAD and Aging: Did We Get the Story Wrong

Page: https://stenobird.com/podcast/the-reprogram-7585130/nad-and-aging-did-we-get-the-story-wrong
Text version: https://stenobird.com/podcast/the-reprogram-7585130/nad-and-aging-did-we-get-the-story-wrong.md
Podcast: [The ReProgram](https://stenobird.com/podcast/the-reprogram-7585130)
Published: 2026-05-18T16:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/thereprogrampodcast/episodes/NAD-and-Aging-Did-We-Get-the-Story-Wrong-e3jflcj
Audio file: https://anchor.fm/s/10b3944a8/podcast/play/120099667/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-17%2F424299595-44100-2-200b59ad1598e.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-reprogram-7585130/episodes/nad-and-aging-did-we-get-the-story-wrong
Duration seconds: 1332

## Resource

ReProgram Episode 14 The NAD Myth? What the New Human Data Really Say 🧠 Episode Overview In this episode of The ReProgram, Dr. George Murphy takes a critical but balanced look at one of the most popular ideas in the longevity space:That NAD levels decline with age — and that boosting NAD may help slow aging.But new human data challenge one of the most common assumptions behind the NAD story:Whole-blood NAD levels may not decline with age.This episode explores what that finding means — and what it does not mean.The central takeaway:NAD is not dead.But the simplistic NAD longevity story needs a reset. 🔑 Keywords NAD, NAD+, aging, longevity, NR, NMN, NAD boosters, nicotinamide riboside, nicotinamide mononucleotide, mitochondrial function, DNA repair, sirtuins, PARPs, CD38, cellular metabolism, biological aging, healthspan, resilience, recovery capacity, inflammation, stress response, biomarker, whole-blood NAD, NAD decline, NAD supplements, NAD IV therapy, metabolism, cellular stress, anti-aging supplements, longevity science, The ReProgram Podcast 🧠 Takeaways • NAD is essential biology, but it should not be treated as a magic anti-aging molecule. • New human data challenge the idea that whole-blood NAD levels universally decline with age. • Raising blood NAD is not the same thing as proving that aging has slowed. • NAD biology is likely tissue-specific, disease-specific, stress-specific, and context-dependent. • Blood NAD is not necessarily a reliable window into NAD metabolism in muscle, brain, liver, immune cells, or other tissues. • NAD boosters like NR and NMN can raise NAD-related metabolites, but that does not automatically mean they improve healthspan or longevity. • The most honest current framing is that NAD boosters are biologically plausible, biomarker-active,…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-reprogram-7585130/episodes/nad-and-aging-did-we-get-the-story-wrong/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-reprogram-7585130/nad-and-aging-did-we-get-the-story-wrong.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.